ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

ACS Community Demonstration Projects Complete, Reach Target Populations, Teach Many Lessons

June 25, 1993

Overall Cancer Mortality Rates Higher For Men Than Women

July 29, 2011

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

Funding opportunities listed.

October 17, 2003

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

May 9, 1997